Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Amneal Pharmaceuticals with status Current. The shortage was first posted on Jul 14, 2023.

Shortage details

Status
Current
Company
Amneal Pharmaceuticals
Package NDC
65162-027-09
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)
Initial Posting
Jul 14, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.